The global whooping cough diagnostics market is growing at significant rates owing to prevalence pertussis. Market players are focusing on the new product developments, acquisitions, partnerships and collaborations. There are many products which are under clinical trials. Whooping cough is also called as pertussis. It is an infection of respiratory system caused by bacterium Bordetella pertussis. It mainly affects babies younger than 6 months old who are not yet protected by immunizations and kids 11 to 18 years old whose immunity has started to fade. The market is expected to experience is a lucrative growth during the forecast period globally owing to the ongoing clinical trials and chances of many nearby approvals. For Instance, in 2014, Quidel Corporation received U.S FDA clearance to market its AmpliVue Bordetella Assay for the detection of Bordetella pertussis nucleic acids and In November 2015, Meridian Bioscience received U.S FDA clearance for new claims for its illumigene Pertussis molecular amplification test.